AGC Expands Production Capacity for Agrochemicals and Pharmaceuticals in Japan

AGC Wakasa Chemicals, part of Japanese group AGC, has completed a new large-scale production line at its Kaminaka Plant in Fukui prefecture, Japan, as it expects demand for agrochemicals and pharmaceuticals to grow steadily against a backdrop of population growth and improvement of living standards.

With the new production line, which was announced back in November 2021, the contract development and manufacturing organization (CDMO) said it will expand its production capacity for synthetic agrochemicals and pharmaceuticals to 1.5 times the current level. The new facility is scheduled to start operations in the first quarter of 2024.

The expansion at the Kaminaka plant, AGC said, will include a new large scale multi-purpose production line that, together with the existing small and medium-scale facilities, will be able to meet demand for a wide range of production volume and chemical synthesis. In addition, the facility will improve collaboration between process development and manufacturing, enabling faster process development and scale-up of synthetic agrochemicals and pharmaceuticals.

As part of its medium-term management plan AGC plus-2023, AGC has positioned its life sciences business, including its CDMO services for synthetic pharmaceuticals and agrochemicals, as one of its strategic business areas. According to AGC, the group aims for steady business expansion through acquisitions and capital investments.

Source: AGC
Source: AGC

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.